[Federal Register Volume 63, Number 78 (Thursday, April 23, 1998)]
[Notices]
[Page 20207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-10876]



[[Page 20207]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meetings:

    Name of SEP: Targeted HIV Vaccine and other Biomedical 
Prevention Research and Development.
    Date: April 29, 1998.
    Time: 1:00 p.m. to Adjournment.
    Place: Teleconference, Solar Building, Room 4C07, 6003 Executive 
Boulevard, Rockville, MD 20892, (301) 496-2550.
    Contact Person: Dr. Dianne E. Tingley, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C07, Bethesda, MD 
20892, (301) 496-2550.
    Purpose/Agenda: To evaluate contract proposals.

    Name of SEP: Immunology Quality Assessment Program.
    Date: May 1, 1998.
    Time: 1:00 p.m. to Adjournment.
    Place: Sheraton Crystal City Hotel-Arlington, 1800 Jefferson 
Davis Highway, Arlington, VA 22202, (703) 486-1111.
    Contact Person: Dr. Edward Schroder, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C38, Bethesda, MD 
20892, (301) 435-8537.
    Purpose/Agenda: To evaluate contract proposals.

    Name of SEP: SPIRAT Supplement.
    Date: May 5, 1998.
    Time: 11:00 a.m. to Adjournment.
    Place: Teleconference, Solar Building, Room 4C05, 6003 Executive 
Boulevard, Bethesda, MD 20892, (301) 496-7966.
    Contact Person: Dr. Allen C. Stoolmiller, Scientific Review 
Adm., 6003 Executive Boulevard, Solar Bldg., Room 4C05, Bethesda, MD 
20892, (301) 496-7966.
    Purpose/Agenda: To evaluate a grant application.
    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

(Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: April 16, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-10876 Filed 4-22-98; 8:45 am]
BILLING CODE 4140-01-M